Comparison of recurrence patterns between patients with thoracic esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and postoperative adjuvant chemoradiotherapy

There was significant difference in the OS and DFS prognosis of patients with ESCC treated with NCRT and ACRT. Recurrence primarily occurs within 2 years following esophagectomy. The recurrence rate was higher in the NCRT group compared to the ACRT group. Patients with early recurrence had a poorer survival prognosis compared to those with late recurrence. Pathological N staging was identified as an independent risk factor affecting OS in the NCRT group. Furthermore, margin status and pathological T staging were independent risk factors influencing OS in the ACRT group.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-06-16
DOI
https://doi.org/10.3389/fonc.2025.1604808
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of recurrence patterns between patients with thoracic esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and postoperative adjuvant chemoradiotherapy

Xuefeng Leng, Haojun Li, Longlin Jiang, Qiang Fang et al.
1 links
Frontiers in Oncology
Esophageal Cancer Research and Treatment
article

Comparison of recurrence patterns between patients with thoracic esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and postoperative adjuvant chemoradiotherapy

Xuefeng Leng, Haojun Li, Longlin Jiang, Qiang Fang, Guangyuan Liu, Yixuan Huang, Wenwu He, Huan Zhang, Lin Peng, Jialong Li, Yongtao Han, Qiang Zhou, Kangning Wang, Kunhan Ni, Simiao Lu, Chenghao Wang
article en

Abstract

There was significant difference in the OS and DFS prognosis of patients with ESCC treated with NCRT and ACRT. Recurrence primarily occurs within 2 years following esophagectomy. The recurrence rate was higher in the NCRT group compared to the ACRT group. Patients with early recurrence had a poorer survival prognosis compared to those with late recurrence. Pathological N staging was identified as an independent risk factor affecting OS in the NCRT group. Furthermore, margin status and pathological T staging were independent risk factors influencing OS in the ACRT group.

Frontiers in OncologyVol. 15
Affiliated Hospital of Southwest Medical University (CN), Sichuan Cancer Hospital (CN)
National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, Chengdu Science and Technology Bureau, Key Research and Development Program of Sichuan Province
Openalex Percentile: Top 76%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.